Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus

OBJECTIVE: To compare the prevalence of human papillomavirus (HPV)-associated vulvovaginal lesions in human immunodeficiency virus (HIV)-positive and HIV-negative women. METHODS: For this cross-sectional study, all participants received a complete gynecologic examination including colposcopic evaluation and a structured interview about sociodemographic characteristics and risk factors for vulvovaginal disease. In addition, HPV DNA was assayed for in cervicovaginal lavages using polymerase chain reaction. RESULTS: Vulvar and/or vaginal condyloma acuminata were detected in 22 of 396 (5.6%) HIV-positive and in 3 of 375 (0.8%) HIV-negative women (odds ratio [OR] 7.3, P < .001). High-grade vulvar intraepithelial neoplasia (VIN) was present in two of the HIV-positive and none of the HIV-negative women. Human immunodeficiency virus-positive women with condyloma or VIN were significantly more likely to have cervical intraepithelial neoplasia (33%) than those without vulvovaginal lesions (17%) (OR 2.9, 95% confidence interval [CI] 1.1, 74). In multivariate logistic regression analysis, both HIV seropositivity (adjusted OR 5.3, 95% CI 1.3, 35.3) and HPV infection (adjusted OR 6.1, 95% CI 1.7, 39.4) were associated with vulvovaginal condyloma. CONCLUSION: The prevalence of vulvovaginal condyloma was increased in HIV-positive women even when controlling for HPV infection. Human papillomavirus-associated disease was more likely to be multicentric and involve the vulva, vagina, and cervix in HIV-positive than HIV-negative women. Detection of high-grade VIN in two of the HIV-positive women suggests that they may also be at risk for developing invasive vulvar carcinoma.

This article has been cited by other articles:

				S. L. Hader, D. K. Smith, J. S. Moore, and S. D. Holmberg HIV Infection in Women in the United States: Status at the Millennium JAMA, March 7, 2001; 285(9): 1186 - 1192. [Abstract] [Full Text] [PDF]

				M. Frisch, R. J. Biggar, and J. J. Goedert Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome J Natl Cancer Inst, September 20, 2000; 92(18): 1500 - 1510. [Abstract] [Full Text] [PDF]

				A. S. De Groot, S. R. Leibel, and S. Zierler A Standard of HIV Care for Incarcerated Women: Northeastern United States' Experiences Journal of Correctional Health Care, October 1, 1998; 5(2): 139 - 177. [Abstract] [PDF]

				M. J. Fink, A. Goodman, E. Hight, E. Miller-Mack, and A. De Groot Critical Prevention, Critical Care: Gynecological and Obstetrical Aspects of Comprehensive HIV Prevention and Treatment Among Incarcerated Women Journal of Correctional Health Care, October 1, 1998; 5(2): 201 - 223. [Abstract] [PDF]

				X.-W. Sun, L. Kuhn, T. V. Ellerbrock, M. A. Chiasson, T. J. Bush, and T. C. Wright Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus N. Engl. J. Med., November 6, 1997; 337(19): 1343 - 1349. [Abstract] [Full Text] [PDF]